Calithera Biosciences (NASDAQ:CALA) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research note issued to investors on Friday morning. The brokerage issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

NASDAQ CALA opened at $0.01 on Friday. The firm’s fifty day moving average price is $0.02 and its 200 day moving average price is $0.02. Calithera Biosciences has a 12 month low of $0.01 and a 12 month high of $0.13.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.